Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator

NCT00175435 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT00175435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00175435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator
Lead sponsor
University of British Columbia
Phase
Phase 1/2
Overall status
Completed
Start date
August 31, 2005
Completion date
April 30, 2007
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b